Anders Poulsen

Structure-based design of oxygen-linked macrocyclic kinase inhibitors: discovery of SB1518 and SB1578, potent inhibitors of Janus kinase 2 (JAK2) and Fms-like tyrosine kinase-3 (FLT3)

Anders Poulsen, Anthony William, Stéphanie Blanchard, 2012, Journal of Computer-Aided Molecular Design.

Pharmacophore Model for Wnt/Porcupine Inhibitors and Its Use in Drug Design

Anders Poulsen, Soo Yei Ho, Weiling Wang, 2015, J. Chem. Inf. Model..

Structure and Ligand-Based Design of mTOR and PI3-Kinase Inhibitors Leading to the Clinical Candidates VS-5584 (SB2343) and SB2602

Anders Poulsen, Stéphanie Blanchard, Angeline Lee, 2014, J. Chem. Inf. Model..

Focal points and payoff information in tacit bargaining

Anders Poulsen, Robert Sugden, Anders U. Poulsen, 2019, Games Econ. Behav..

Sender-Receiver Games with Endogenous Ex-Post Information Acquisition: Experimental Evidence

Anders Poulsen, Graciela Zevallos-Porles, 2019 .

Structure-based design of Aurora A & B inhibitors

Eric Sun, Anders Poulsen, Anthony William, 2008, J. Comput. Aided Mol. Des..

nonaene ( SB 1578 ) , a Potent Inhibitor of Janus Kinase 2 / Fms-LikeTyrosine Kinase-3 ( JAK 2 / FLT 3 ) for the Treatment of Rheumatoid Arthritis

Anders Poulsen, Harish Nagaraj, Evelyn Tan, 2012 .

Targeting the Bacterial Epitranscriptome for Antibiotic Development: Discovery of Novel tRNA-(N1G37) Methyltransferase (TrmD) Inhibitors.

Anders Poulsen, Yan Li, Alex Matter, 2019, ACS infectious diseases.

Discovery of the macrocycle 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene (SB1518), a potent Janus kinase 2/fms-like tyrosine kinase-3 (JAK2/FLT3) inhibitor for the treatment of myelofibrosis and lympho

Anders Poulsen, Stéphanie Blanchard, Harish Nagaraj, 2011, Journal of medicinal chemistry.